Search hospitals > Tennessee > Memphis
St Jude Children's Research Hospital
Claim this profileMemphis, Tennessee 38105
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Adult T-Cell Leukemia/Lymphoma
Conducts research for Solid Tumors
Conducts research for Lymphoma
911 reported clinical trials
67 medical researchers
Summary
St Jude Children's Research Hospital is a medical facility located in Memphis, Tennessee. This center is recognized for care of Cancer, Brain Tumor, Adult T-Cell Leukemia/Lymphoma, Solid Tumors, Lymphoma and other specialties. St Jude Children's Research Hospital is involved with conducting 911 clinical trials across 891 conditions. There are 67 research doctors associated with this hospital, such as Alberto S. Pappo, Jeffrey E. Rubnitz, MD, PhD, Giles Robinson, MD, and Jessica Gartrell.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Brain Tumor
Global LeaderBRAF positive
Stage IV
NTRK positive
Top PIs
Alberto S. PappoSaint Jude Children's Research Hospital9 years of reported clinical research
Expert in Cancer
Expert in Brain Tumor
24 reported clinical trials
42 drugs studied
Jeffrey E. Rubnitz, MD, PhDSt. Jude Children's Research Hospital5 years of reported clinical research
Expert in Adult T-Cell Leukemia/Lymphoma
Studies Acute Myeloid Leukemia
13 reported clinical trials
25 drugs studied
Giles Robinson, MDSt. Jude Children's Research Hospital9 years of reported clinical research
Studies Brain Tumor
Studies Solid Tumors
13 reported clinical trials
29 drugs studied
Jessica GartrellSaint Jude Children's Research Hospital3 years of reported clinical research
Studies Cancer
Studies Solid Tumors
12 reported clinical trials
24 drugs studied
Clinical Trials running at St Jude Children's Research Hospital
Acute Lymphoblastic Leukemia
Cancer
Brain Tumor
Adult T-Cell Leukemia/Lymphoma
Sickle Cell Disease
Lymphoid Hematopoietic Disease
Acute Myeloid Leukemia
Wilms Tumor
Testicular cancer
Lymphoma
Combination Therapy
for Acute Lymphoblastic Leukemia
The goal of this study is to provide sufficient therapy during the time a patients' B-cell Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy) risk category is being determined. The term "risk" refers to the chance of the ALL or LLy coming back after treatment. Primary Objectives * To provide sufficient therapy to enable testing of newly diagnosed acute lymphoblastic leukemia/lymphoma and mixed phenotype acute leukemia/lymphoma tumor samples to determine eligibility and appropriate risk stratification for SJALL therapeutic studies. * To develop a central database of genomic and clinical findings. Secondary Objectives * To assess event free and overall survival data of patients enrolled on this study.
Recruiting3 awards Phase 4
New Therapies
for Acute Lymphoblastic Leukemia
This is a Phase II clinical trial testing the use of two antigen-directed therapies, inotuzumab and blinatumomab, as part of induction therapy for children and young adults with newly diagnosed B-cell precursor acute lymphoblastic leukemia and lymphoma. Primary Objective * To assess if the flow-cytometry assessed MRD-negative remission rate following an immunotherapy-based Induction in NCI-high risk patients without favorable genetic features is higher than the results of similar patients treated on AALL1131. Secondary Objectives * To compare flow-cytometry assessed MRD-negative rates at the end of Induction for patients treated with this therapy compared to similar patients treated on TOT17. * To compare the rate of significant toxicities in patients treated with this therapy to those treated with standard-risk therapy on TOT17. * To assess the event free and overall survival of patients treated with this therapy.
Recruiting1 award Phase 25 criteria
CAR T-cell Therapy
for Blood Cancers
The study participant has one of the following blood cancers: acute myelogenous leukemia (AML)/myelodysplastic syndrome (MDS), acute lymphoblastic leukemia (B-ALL, T-ALL) or Lymphoma. Your cancer has been difficult to treat (refractory) or has come back after treatment (relapse). Primary Objective To determine the safety and maximum tolerated dose of intravenous infusions of escalating doses of CD70-CAR T cells in patients (≤21 years) with recurrent/refractory CD70+ hematological malignancies after lymphodepleting chemotherapy. Secondary Objectives To evaluate the antileukemic activity of CD70-CAR T cells. We will determine the anti- leukemic activity of the CD70-CAR T cells in the bone marrow and in the treatment of extramedullary disease.
Recruiting1 award Phase 1
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at St Jude Children's Research Hospital?
St Jude Children's Research Hospital is a medical facility located in Memphis, Tennessee. This center is recognized for care of Cancer, Brain Tumor, Adult T-Cell Leukemia/Lymphoma, Solid Tumors, Lymphoma and other specialties. St Jude Children's Research Hospital is involved with conducting 911 clinical trials across 891 conditions. There are 67 research doctors associated with this hospital, such as Alberto S. Pappo, Jeffrey E. Rubnitz, MD, PhD, Giles Robinson, MD, and Jessica Gartrell.
Where is St Jude Children's Research Hospital located?
St. Jude Children's Research Hospital is located at 262 Danny Thomas Place, Memphis, TN, approximately 10 miles southeast of downtown Memphis, near the Mississippi River.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance-related inquiries at St. Jude Children's Research Hospital, the following contacts are available:
- **Financial Assistance**: Contact the Financial Assistance Department at 901-595-5466 or 901-595-0347 for concerns about hospital bill payments.
- **Patient Assistance Coordinator**: For financial support during treatment, resource connection, and insurance billing or payment questions, reach out to a patient assistance coordinator at 901-595-3957 or 901-438-2138.
- **Hospital Main Line**: For general inquiries, call 866-278-5833.
- **Revenue Integrity**: For insurance, pricing, or financial assistance questions, contact Danny Winchester at 901-595-2186 or email RevenueIntegrity@StJude.org.
What insurance does St Jude Children's Research Hospital accept?
St. Jude Children's Research Hospital accepts various insurance plans, covering treatment costs, copayments, deductibles, coinsurance, and any other costs not covered by insurance. The hospital does not bill patients, ensuring care is provided regardless of the ability to pay, through billing insurance plans or covering costs for uninsured patients. Patients are encouraged to review their insurance documents to understand coverage and consult their care team for any coverage concerns.
What awards or recognition has St Jude Children's Research Hospital received?
St. Jude Children's Research Hospital, located in Memphis, Tennessee, is renowned for its innovative Blue-Sky program, which has garnered over $50 million in funding for employee-generated projects. The hospital boasts a four-out-of-four star rating from Charity Navigator and has been recognized as one of America's Best Employers By State by Forbes in 2023.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.